Although the SAKK/CECOG trial did not achieve statistical significance for survival, it used a less dose-intense schedule of the gemcitabine/capecitabine combination compared with the UK GemCap trial and it was also comparatively underpowered.
In the study, 82 patients died while receiving the combination, compared with just 51 who received Lipitor alone.
Additionally, they reported that the statistical incidence of adverse reactions was no greater with the steroid/anti-infective combination compared with the separate components [15].
The objective of this study was to evaluate the efficacy and safety of the lercanidipine/valsartan combination compared with lercanidipine monotherapy in patients with hypertension.
There were 62% fewer HIV infections in the group on the single drug and 73% fewer HIV infections in the group that took the combination, compared with those given a dummy pill.
Adverse events were uncommon during this study and treatment emergent adverse events were statistically significantly less frequent in the groups taking the ibuprofen/paracetamol combination compared with codeine combinations.
Our study was the first randomized field trial to assess a doxycycline-chloroquine combination as malaria prophylaxis and showed no significant decrease of overall tolerability of the combination compared with doxycycline alone.
At 45% and 60% loads the optimum factor combination compared with the original baseline diesel engine reduces 14.52% for BSFC, 60.5% for NOX and for 42.28% smoke and improves combustion performance such as peak in-cylinder pressure and net heat-release rate.
The results show that H3K9me2 level was markedly reduced in cells treated with the three-drug combination, compared with cells treated with DZNep/TSA, while H3K27me3 levels remained the same (Figure 5C).
Consistent with the previously observed capacity of methotrexate to enhance the potency of BIO in RKO cells, LPS-induced production of pro-inflammatory cytokines was severely blunted, whereas production of IL-10 was significantly increased in PBMCs pre-treated with the drug combination compared with cells pre-treated with either methotrexate or BIO alone (Figure 7).
At 1 year, survival rates were 18% for the combination compared with 10% for paclitaxel alone.
